MicroRNA‑125b reduces glucose uptake in papillary thyroid carcinoma cells
- Guowu Zhang
- Sihai Zhou
- Quan Yang
- Fang Liu
Affiliations: Department of General Surgery, Yongchuan Hospital of Chongqing Medical University, Chongqing 402160, P.R. China, Department of Radiology, Yongchuan Hospital of Chongqing Medical University, Chongqing 402160, P.R. China
- Published online on: July 8, 2020 https://doi.org/10.3892/ol.2020.11832
Copyright: © Zhang
et al. This is an open access article distributed under the
terms of Creative
Commons Attribution License.
Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
This article is mentioned in:
Previous studies have shown that microRNA (miR)‑125b plays important roles in several human cancer types. The aim of the present study was to analyze the potential roles of miR‑125b in papillary thyroid carcinoma (PTC). It was found that miR‑125b was downregulated in PTC and its expression was affected by clinical stages. Glucose transporter 1 (GLUT1) was upregulated in PTC and was negatively correlated with miR‑125b. In PTC cells, overexpression of miR‑125b suppressed glucose uptake and downregulated GLUT1. Furthermore, GLUT1 overexpression reduced the effects of miR‑125b overexpression on glucose uptake. Moreover, miR‑125b overexpression suppressed PTC cell proliferation. GLUT1 overexpression promoted the proliferation of PTC cells and reduced the effects of miR‑125b overexpression on cancer cell proliferation. Overall, miR‑125b decreased glucose uptake in PTC cells by downregulating GLUT1.